Biodexa Pharmaceuticals Plc (BDRX)

USD 1.4

(-0.71%)

EBITDA Summary of Biodexa Pharmaceuticals Plc

  • Biodexa Pharmaceuticals Plc's latest annual EBITDA in 2023 was -6.45 Million GBP , up 12.64% from previous year.
  • Biodexa Pharmaceuticals Plc's latest quarterly EBITDA in 2024 Q2 was -2.07 Million GBP , down 0.0% from previous quarter.
  • Biodexa Pharmaceuticals Plc reported an annual EBITDA of -7.39 Million GBP in 2022, down -29.03% from previous year.
  • Biodexa Pharmaceuticals Plc reported an annual EBITDA of -5.65 Million GBP in 2021, up 29.12% from previous year.
  • Biodexa Pharmaceuticals Plc reported a quarterly EBITDA of -2.07 Million GBP for 2024 Q1, down -81.68% from previous quarter.
  • Biodexa Pharmaceuticals Plc reported a quarterly EBITDA of -1.14 Million GBP for 2023 Q3, up 45.17% from previous quarter.

Annual EBITDA Chart of Biodexa Pharmaceuticals Plc (2023 - 2012)

Historical Annual EBITDA of Biodexa Pharmaceuticals Plc (2023 - 2012)

Year EBITDA EBITDA Growth
2023 -6.45 Million GBP 12.64%
2022 -7.39 Million GBP -29.03%
2021 -5.65 Million GBP 29.12%
2020 -22.21 Million GBP 7.39%
2019 -9.54 Million GBP 3.44%
2018 -10.7 Million GBP -0.9%
2017 -10.6 Million GBP -100.09%
2016 -5.3 Million GBP 43.33%
2015 -10.49 Million GBP -26.54%
2014 -9.35 Million GBP -73.85%
2013 -4.25 Million GBP -11.51%
2012 -3.81 Million GBP 0.0%

Peer EBITDA Comparison of Biodexa Pharmaceuticals Plc

Name EBITDA EBITDA Difference
Sangamo Therapeutics, Inc. -87.42 Million USD 92.613%
IDEAYA Biosciences, Inc. -130.42 Million USD 95.048%
Eton Pharmaceuticals, Inc. -291 Thousand USD -2119.244%
Autolus Therapeutics plc -156.77 Million USD 95.881%
Greenwich LifeSciences, Inc. -9.32 Million USD 30.74%
Enlivex Therapeutics Ltd. -28.21 Million USD 77.115%
Shattuck Labs, Inc. -87.61 Million USD 92.629%
LENZ Therapeutics, Inc. -122.24 Million USD 94.717%
CervoMed Inc. -2.17 Million USD -197.347%
Rocket Pharmaceuticals, Inc. -236.62 Million USD 97.271%
Corbus Pharmaceuticals Holdings, Inc. -44.43 Million USD 85.467%
Aptose Biosciences Inc. -52.26 Million USD 87.644%
Precision BioSciences, Inc. -32.04 Million USD 79.845%
Dyadic International, Inc. -8.22 Million USD 21.528%
TScan Therapeutics, Inc. -80.09 Million USD 91.937%
Intensity Therapeutics, Inc. -10.08 Million USD 35.971%
Nektar Therapeutics -243.1 Million USD 97.344%
CytomX Therapeutics, Inc. -4.3 Million USD -49.872%
VYNE Therapeutics Inc. -29.25 Million USD 77.927%
EyePoint Pharmaceuticals, Inc. -69 Million USD 90.641%
Leap Therapeutics, Inc. -80.98 Million USD 92.026%
Adaptive Biotechnologies Corporation -189.27 Million USD 96.588%
GRI Bio, Inc. -10.89 Million USD 40.741%
Xenetic Biosciences, Inc. -4.51 Million USD -43.012%
Tenaya Therapeutics, Inc. -122.5 Million USD 94.728%
NeuroSense Therapeutics Ltd. -10.63 Million USD 39.265%
Psyence Biomedical Ltd. -2.75 Million USD -134.702%
IGM Biosciences, Inc. -253.35 Million USD 97.451%
INmune Bio, Inc. - USD Infinity%
Opthea Limited -200.01 Million USD 96.771%
Milestone Pharmaceuticals Inc. -56.84 Million USD 88.639%
Omega Therapeutics, Inc. -93.49 Million USD 93.092%
Verastem, Inc. -83.16 Million USD 92.235%
Abeona Therapeutics Inc. -50.57 Million USD 87.23%
Pliant Therapeutics, Inc. -158.22 Million USD 95.919%
Tonix Pharmaceuticals Holding Corp. -114.08 Million USD 94.34%
Ligand Pharmaceuticals Incorporated 101.72 Million USD 106.348%
NextCure, Inc. -59.03 Million USD 89.061%
Inhibikase Therapeutics, Inc. -19.91 Million USD 67.568%
Organovo Holdings, Inc. -14.8 Million USD 56.383%
Lixte Biotechnology Holdings, Inc. 3207.00 USD 201471.999%
Arvinas, Inc. -394.8 Million USD 98.364%
Ovid Therapeutics Inc. -58.71 Million USD 89.001%
CASI Pharmaceuticals, Inc. -21.53 Million USD 70.017%
Rani Therapeutics Holdings, Inc. -65.27 Million USD 90.107%
Centessa Pharmaceuticals plc -166.06 Million USD 96.111%
Arcturus Therapeutics Holdings Inc. -24.16 Million USD 73.277%
Syros Pharmaceuticals, Inc. -157.19 Million USD 95.892%
Senti Biosciences, Inc. -61.33 Million USD 89.471%
BioRestorative Therapies, Inc. -15.05 Million USD 57.104%
Apollomics, Inc. -171.74 Million USD 96.24%
PureTech Health plc -11.62 Million USD 44.457%
Oncternal Therapeutics, Inc. 2.23 Million USD 388.949%
Barinthus Biotherapeutics plc -74.81 Million USD 91.368%
Kymera Therapeutics, Inc. -143.2 Million USD 95.49%
Synaptogenix, Inc. -8.3 Million USD 22.263%
ChromaDex Corporation -3.89 Million USD -65.845%
Beam Therapeutics Inc. -156.47 Million USD 95.873%
Monopar Therapeutics Inc. 429.03 Thousand USD 1605.224%
Akebia Therapeutics, Inc. -6.86 Million USD 5.97%
Nurix Therapeutics, Inc. -141.4 Million USD 95.433%
Apellis Pharmaceuticals, Inc. -495.21 Million USD 98.696%
Dermata Therapeutics, Inc. 247.21 Thousand USD 2712.29%
Gritstone bio, Inc. -126.86 Million USD 94.909%
Mesoblast Limited -61.33 Million USD 89.47%
Virpax Pharmaceuticals, Inc. -2.24 Million USD -187.058%
Xeris Biopharma Holdings, Inc. -23.73 Million USD 72.791%
Fate Therapeutics, Inc. -172.22 Million USD 96.25%
MediWound Ltd. -4.89 Million USD -31.984%
BioXcel Therapeutics, Inc. -165.42 Million USD 96.096%
Fortress Biotech, Inc. -133.64 Million USD 95.168%
Fractyl Health, Inc. Common Stock -50.55 Million USD 87.225%
Achilles Therapeutics plc -70.44 Million USD 90.832%
Seres Therapeutics, Inc. -85.43 Million USD 92.441%
Checkpoint Therapeutics, Inc. -52.14 Million USD 87.616%
Atossa Therapeutics, Inc. -31.35 Million USD 79.403%
Zai Lab Limited -366.57 Million USD 98.238%
Fresh Tracks Therapeutics, Inc. -5.64 Million USD -14.341%
Lyell Immunopharma, Inc. -225.24 Million USD 97.133%
Vanda Pharmaceuticals Inc. -10.94 Million USD 40.98%
Tarsus Pharmaceuticals, Inc. -131.67 Million USD 95.095%
InMed Pharmaceuticals Inc. -7.06 Million USD 8.578%
FibroGen, Inc. -261.4 Million USD 97.53%
Celcuity Inc. -58.3 Million USD 88.925%
SeaStar Medical Holding Corporation -11.14 Million USD 42.034%
ContextLogic Inc. -324 Million USD 98.007%
GH Research PLC -41.15 Million USD 84.307%
HOOKIPA Pharma Inc. -77.34 Million USD 91.65%
Cyclacel Pharmaceuticals, Inc. -25.42 Million USD 74.597%
ImmuCell Corporation -2.5 Million USD -157.899%
Amylyx Pharmaceuticals, Inc. 39.89 Million USD 116.19%
Amarin Corporation plc -50.9 Million USD 87.313%
TG Therapeutics, Inc. 26.1 Million USD 124.743%
Aptevo Therapeutics Inc. -28.31 Million USD 77.189%
Jasper Therapeutics, Inc. -64.98 Million USD 90.062%
Foghorn Therapeutics Inc. -104.45 Million USD 93.817%
Y-mAbs Therapeutics, Inc. -25.67 Million USD 74.844%
Aptorum Group Limited -9.59 Million USD 32.722%
Ultragenyx Pharmaceutical Inc. -516.45 Million USD 98.75%
BioCryst Pharmaceuticals, Inc. -116.33 Million USD 94.449%
Chemomab Therapeutics Ltd. -25.39 Million USD 74.567%
Arrowhead Pharmaceuticals, Inc. -175.67 Million USD 96.324%
TransCode Therapeutics, Inc. -17.97 Million USD 64.069%
RAPT Therapeutics, Inc. -125.84 Million USD 94.868%
Ardelyx, Inc. -55.35 Million USD 88.333%
Ainos, Inc. -8.77 Million USD 26.389%
Lyra Therapeutics, Inc. -65.25 Million USD 90.103%
Prothena Corporation plc -190.1 Million USD 96.603%
HilleVax, Inc. -132.46 Million USD 95.125%
Adaptimmune Therapeutics plc -128.19 Million USD 94.962%
Celularity Inc. -183.94 Million USD 96.489%
Rallybio Corporation -72.37 Million USD 91.077%
Cue Biopharma, Inc. -46.05 Million USD 85.977%
Omeros Corporation -163.61 Million USD 96.053%
Humacyte, Inc. -96.45 Million USD 93.305%
Immunocore Holdings plc -59.64 Million USD 89.173%
Cocrystal Pharma, Inc. -19.37 Million USD 66.663%
Blueprint Medicines Corporation -474.61 Million USD 98.639%
IO Biotech, Inc. -91.22 Million USD 92.921%
MEI Pharma, Inc. 26.38 Million USD 124.481%
GT Biopharma, Inc. 5.97 Million USD 208.011%
Cabaletta Bio, Inc. -73.23 Million USD 91.182%
Summit Therapeutics Inc. 1 Million USD 745.155%
Alaunos Therapeutics, Inc. -30.9 Million USD 79.103%
Marinus Pharmaceuticals, Inc. -125.49 Million USD 94.854%
Scholar Rock Holding Corporation -168.45 Million USD 96.166%
Pulmatrix, Inc. -12.64 Million USD 48.932%
Elicio Therapeutics, Inc. -32.96 Million USD 80.41%
X4 Pharmaceuticals, Inc. -107.1 Million USD 93.97%
Vigil Neuroscience, Inc. -88.46 Million USD 92.7%
Acelyrin, Inc. -381.52 Million USD 98.307%
Intellia Therapeutics, Inc. -506.31 Million USD 98.725%
Cytokinetics, Incorporated -456.68 Million USD 98.586%
Vor Biopharma Inc. -114.37 Million USD 94.353%
Evogene Ltd. -23.2 Million USD 72.169%
Replimune Group, Inc. -230.19 Million USD 97.195%
Applied Therapeutics, Inc. -64.53 Million USD 89.993%
PDS Biotechnology Corporation -40.08 Million USD 83.889%
Hoth Therapeutics, Inc. -153.14 Thousand USD -4116.808%
BridgeBio Pharma, Inc. -565.46 Million USD 98.858%
AEON Biopharma, Inc. -48.36 Million USD 86.646%
BioLineRx Ltd. -57.06 Million USD 88.682%
Galectin Therapeutics Inc. -202 Thousand USD -3097.03%
Atai Life Sciences N.V. -36.31 Million USD 82.215%
Aerovate Therapeutics, Inc. -81.31 Million USD 92.058%
VistaGen Therapeutics, Inc. -32.45 Million USD 80.1%
Zentalis Pharmaceuticals, Inc. -275.5 Million USD 97.656%
Sagimet Biosciences Inc. -30.74 Million USD 78.992%
MediciNova, Inc. -9.87 Million USD 34.635%
Praxis Precision Medicines, Inc. -125.94 Million USD 94.872%
MiMedx Group, Inc. 40.51 Million USD 115.939%
Cardio Diagnostics Holdings, Inc. -1.53 Million USD -322.036%
Axsome Therapeutics, Inc. -224.99 Million USD 97.13%
PTC Therapeutics, Inc. -330.34 Million USD 98.045%
Mereo BioPharma Group plc -26.05 Million USD 75.215%
Syndax Pharmaceuticals, Inc. -229.94 Million USD 97.191%
NRx Pharmaceuticals, Inc. -30.02 Million USD 78.491%
Dyne Therapeutics, Inc. -233.47 Million USD 97.234%
BriaCell Therapeutics Corp. -4.79 Million USD -34.781%
Allakos Inc. -189.91 Million USD 96.6%
scPharmaceuticals Inc. -46.06 Million USD 85.979%
Fulcrum Therapeutics, Inc. -108.49 Million USD 94.047%
Corcept Therapeutics Incorporated 108.32 Million USD 105.962%
NLS Pharmaceutics AG -11.79 Million USD 45.251%
Precigen, Inc. -89.22 Million USD 92.762%
XOMA Corporation -39.36 Million USD 83.593%
Kezar Life Sciences, Inc. -99.25 Million USD 93.493%
Incyte Corporation 919.42 Million USD 100.702%
Alzamend Neuro, Inc. -9.88 Million USD 34.681%
Cara Therapeutics, Inc. -117.65 Million USD 94.511%
Aligos Therapeutics, Inc. -83.81 Million USD 92.295%
Seer, Inc. -97.88 Million USD 93.402%
Reviva Pharmaceuticals Holdings, Inc. -24.11 Million USD 73.217%
CRISPR Therapeutics AG -202.7 Million USD 96.814%
Akero Therapeutics, Inc. -148.63 Million USD 95.655%
Eliem Therapeutics, Inc. -13.65 Million USD 52.699%
EyeGate Pharmaceuticals, Inc. -8.04 Million USD 19.7%
Akari Therapeutics, Plc -16.8 Million USD 61.564%
Novavax, Inc. -487.39 Million USD 98.675%
Lexaria Bioscience Corp. -6.38 Million USD -1.086%
UroGen Pharma Ltd. -63.83 Million USD 89.883%
Sutro Biopharma, Inc. -67.91 Million USD 90.491%
Entera Bio Ltd. -8.8 Million USD 26.647%
Lisata Therapeutics, Inc. -25.51 Million USD 74.693%
Stoke Therapeutics, Inc. -112.3 Million USD 94.25%
Chimerix, Inc. -92.97 Million USD 93.054%
Reneo Pharmaceuticals, Inc. -82.23 Million USD 92.147%
Phathom Pharmaceuticals, Inc. -159.04 Million USD 95.94%
Outlook Therapeutics, Inc. -57.37 Million USD 88.744%
Jazz Pharmaceuticals plc 1.44 Billion USD 100.446%
AnaptysBio, Inc. -143.16 Million USD 95.489%
Aprea Therapeutics, Inc. -14.27 Million USD 54.775%
Portage Biotech Inc. -18.19 Million USD 64.515%
Olema Pharmaceuticals, Inc. -104.58 Million USD 93.825%
PMV Pharmaceuticals, Inc. -78.87 Million USD 91.812%
OKYO Pharma Limited -15.74 Thousand USD -40913.929%
Qualigen Therapeutics, Inc. -11.3 Million USD 42.851%
Cadrenal Therapeutics, Inc. Common Stock -8.33 Million USD 22.547%
Processa Pharmaceuticals, Inc. -11.45 Million USD 43.632%
AbCellera Biologics Inc. -192.15 Million USD 96.639%
Genprex, Inc. -31.06 Million USD 79.208%
Neumora Therapeutics, Inc. Common Stock -187.52 Million USD 96.556%
NLS Pharmaceutics AG -11.79 Million USD 45.251%
Virios Therapeutics, Inc. 150.9 Thousand USD 4379.542%
Daré Bioscience, Inc. -30.7 Million USD 78.965%
Titan Pharmaceuticals, Inc. -7.16 Million USD 9.867%
Bicycle Therapeutics plc -183.4 Million USD 96.479%
Revolution Medicines, Inc. Warrant -430.58 Million USD 98.5%
Protagonist Therapeutics, Inc. -90.34 Million USD 92.851%
Erasca, Inc. -121.31 Million USD 94.676%
bluebird bio, Inc. -167.16 Million USD 96.137%
Pieris Pharmaceuticals, Inc. -22.76 Million USD 71.628%
BioMarin Pharmaceutical Inc. 310.28 Million USD 102.081%
DBV Technologies S.A. -85.98 Million USD 92.489%
Fortress Biotech, Inc. -133.64 Million USD 95.168%
Avidity Biosciences, Inc. -233.49 Million USD 97.234%
CorMedix Inc. -48.88 Million USD 86.79%
Travere Therapeutics, Inc. -326.24 Million USD 98.021%
Sensei Biotherapeutics, Inc. -33.38 Million USD 80.657%
Orchestra BioMed Holdings, Inc. -51.21 Million USD 87.391%
Spruce Biosciences, Inc. -47.36 Million USD 86.366%
Celldex Therapeutics, Inc. -139.03 Million USD 95.355%
Cartesian Therapeutics, Inc. -235.06 Million USD 97.253%
Cogent Biosciences, Inc. -205.86 Million USD 96.863%
Onconetix, Inc. -36.7 Million USD 82.406%
Ocuphire Pharma, Inc. -9.96 Million USD 35.213%
Prime Medicine, Inc. -193.75 Million USD 96.667%
Adagene Inc. -14.95 Million USD 56.805%
Inhibrx Biosciences, Inc. -206.69 Million USD 96.876%
GlycoMimetics, Inc. -39.12 Million USD 83.493%
Maravai LifeSciences Holdings, Inc. 712.4 Million USD 100.907%
Verve Therapeutics, Inc. -217.66 Million USD 97.033%
Voyager Therapeutics, Inc. 126.45 Million USD 105.107%
SciSparc Ltd. -5.28 Million USD -22.264%
Revelation Biosciences, Inc. -95.2 Thousand USD -6683.043%
Minerva Neurosciences, Inc. -21.69 Million USD 70.228%
Astria Therapeutics, Inc. -83.03 Million USD 92.222%
Spero Therapeutics, Inc. 27.15 Million USD 123.783%
Tevogen Bio Holdings Inc. 188.7 Thousand USD 3522.255%
Arcutis Biotherapeutics, Inc. -227.43 Million USD 97.16%
Marker Therapeutics, Inc. -11.79 Million USD 45.235%
Alnylam Pharmaceuticals, Inc. -258.24 Million USD 97.499%
Artelo Biosciences, Inc. -10.28 Million USD 37.21%
2seventy bio, Inc. -206.41 Million USD 96.871%
ADMA Biologics, Inc. 5.12 Million USD 226.133%
Clene Inc. -43.24 Million USD 85.065%
Capricor Therapeutics, Inc. -23 Million USD 71.933%
Boundless Bio, Inc. Common Stock -48.47 Million USD 86.678%
Recursion Pharmaceuticals, Inc. -299.56 Million USD 97.844%
Citius Pharmaceuticals, Inc. -36.72 Million USD 82.417%
Contineum Therapeutics, Inc. Class A Common Stock 23.57 Million USD 127.396%
Absci Corporation -95.45 Million USD 93.235%
Regeneron Pharmaceuticals, Inc. 4.65 Billion USD 100.139%
Surrozen, Inc. -41.13 Million USD 84.299%
Caribou Biosciences, Inc. -112.53 Million USD 94.261%
Janux Therapeutics, Inc. -71.02 Million USD 90.907%
Cingulate Inc. -22.95 Million USD 71.863%
Galmed Pharmaceuticals Ltd. -7.46 Million USD 13.443%
Tenax Therapeutics, Inc. -8.22 Million USD 21.496%
Jaguar Health, Inc. -33.13 Million USD 80.508%
Terns Pharmaceuticals, Inc. -102.26 Million USD 93.685%
ACADIA Pharmaceuticals Inc. -67.82 Million USD 90.479%
Kronos Bio, Inc. -121.83 Million USD 94.699%
Innoviva, Inc. 248.96 Million USD 102.594%
Bolt Biotherapeutics, Inc. -74.34 Million USD 91.313%
Entrada Therapeutics, Inc. -321 Thousand USD -1911.838%
ZyVersa Therapeutics, Inc. -107.74 Million USD 94.006%
Soligenix, Inc. -7.85 Million USD 17.762%
AlloVir, Inc. -190.14 Million USD 96.604%
Century Therapeutics, Inc. -121.2 Million USD 94.672%
ORIC Pharmaceuticals, Inc. -109.74 Million USD 94.116%
Kura Oncology, Inc. -164.95 Million USD 96.085%
Ocean Biomedical, Inc. -957.73 Thousand USD -574.296%
Mineralys Therapeutics, Inc. -84.65 Million USD 92.372%
Eterna Therapeutics Inc. -19.93 Million USD 67.603%
SELLAS Life Sciences Group, Inc. 529 Thousand USD 1320.794%
Heron Therapeutics, Inc. -103.79 Million USD 93.778%
SAB Biotherapeutics, Inc. -38.13 Million USD 83.065%
Pasithea Therapeutics Corp. -15.33 Million USD 57.876%
Entero Therapeutics, Inc. -15.74 Million USD 58.979%
HCW Biologics Inc. -23.57 Million USD 72.608%
C4 Therapeutics, Inc. -122.1 Million USD 94.711%
Atara Biotherapeutics, Inc. -265.99 Million USD 97.572%
Coherus BioSciences, Inc. -193.93 Million USD 96.67%
Lantern Pharma Inc. -15.78 Million USD 59.092%
Histogen Inc. -10.5 Million USD 38.513%
Surrozen, Inc. -41.13 Million USD 84.299%
Eledon Pharmaceuticals, Inc. - USD Infinity%
Kodiak Sciences Inc. -259.02 Million USD 97.507%
MoonLake Immunotherapeutics -54.1 Million USD 88.065%
Hepion Pharmaceuticals, Inc. -49.25 Million USD 86.89%
Adverum Biotechnologies, Inc. -112.59 Million USD 94.265%
Avalo Therapeutics, Inc. -27.95 Million USD 76.899%
Moderna, Inc. -3.28 Billion USD 99.803%
Ionis Pharmaceuticals, Inc. -230.01 Million USD 97.192%
Turnstone Biologics Corp. -56.23 Million USD 88.516%
Immix Biopharma, Inc. -16.13 Million USD 59.977%
Tiziana Life Sciences Ltd -15.33 Million USD 57.898%
Aurinia Pharmaceuticals Inc. -63.04 Million USD 89.757%
Exelixis, Inc. 196.6 Million USD 103.285%
Monte Rosa Therapeutics, Inc. -137.08 Million USD 95.289%
Wave Life Sciences Ltd. -58.79 Million USD 89.015%
Conduit Pharmaceuticals Inc. -324 Thousand USD -1893.21%
Alkermes plc 495.04 Million USD 101.305%
Jasper Therapeutics, Inc. -64.98 Million USD 90.062%
Arcellx, Inc. -64.14 Million USD 89.932%
ESSA Pharma Inc. -26.45 Million USD 75.589%
TNF Pharmaceuticals, Inc. -3.99 Million USD -61.452%
Avid Bioservices, Inc. -11.48 Million USD 43.751%
Insmed Incorporated -654.73 Million USD 99.014%
Cardiff Oncology, Inc. -45.01 Million USD 85.653%
Enanta Pharmaceuticals, Inc. -123.47 Million USD 94.77%
Moolec Science SA -52.07 Million USD 87.599%
RenovoRx, Inc. -11.39 Million USD 43.301%
Acumen Pharmaceuticals, Inc. -51.6 Million USD 87.486%
Geron Corporation -174.78 Million USD 96.305%
LAVA Therapeutics N.V. -40.41 Million USD 84.022%
Verrica Pharmaceuticals Inc. -62.19 Million USD 89.617%
Royalty Pharma plc 1.88 Billion USD 100.342%
OmniAb, Inc. -49.73 Million USD 87.014%
Alector, Inc. -142.89 Million USD 95.481%
Atea Pharmaceuticals, Inc. -119.59 Million USD 94.6%
Mersana Therapeutics, Inc. -166.08 Million USD 96.112%
Humacyte, Inc. -96.45 Million USD 93.305%
Structure Therapeutics Inc. -102.45 Million USD 93.697%
Revance Therapeutics, Inc. -290.63 Million USD 97.778%
89bio, Inc. -134.46 Million USD 95.197%
Avenue Therapeutics, Inc. 4.05 Million USD 259.378%
Aura Biosciences, Inc. -83.69 Million USD 92.284%
Immunic, Inc. -99.11 Million USD 93.484%
Veracyte, Inc. -49.4 Million USD 86.93%
Genelux Corporation -24.16 Million USD 73.275%
Trevi Therapeutics, Inc. -33.8 Million USD 80.893%
Adial Pharmaceuticals, Inc. -7 Million USD 7.76%
Sonnet BioTherapeutics Holdings, Inc. -18.71 Million USD 65.496%
Immunovant, Inc. -269.97 Million USD 97.608%
Vericel Corporation 2.86 Million USD 325.489%
Fortrea Holdings Inc. 167.3 Million USD 103.86%
KalVista Pharmaceuticals, Inc. -134.28 Million USD 95.191%
XBiotech Inc. -35.76 Million USD 81.944%
Agenus Inc. -145.92 Million USD 95.574%
Acasti Pharma Inc. -11.3 Million USD 42.855%
Kiora Pharmaceuticals, Inc. -12.35 Million USD 47.709%
MiNK Therapeutics, Inc. -22.25 Million USD 70.98%
Pasithea Therapeutics Corp. -15.33 Million USD 57.876%
Theravance Biopharma, Inc. -40.86 Million USD 84.198%
Metagenomi, Inc. Common Stock -56.02 Million USD 88.472%
NeuroBo Pharmaceuticals, Inc. -15.88 Million USD 59.332%
Gain Therapeutics, Inc. -22.16 Million USD 70.87%
Tempest Therapeutics, Inc. -28.77 Million USD 77.558%
Sol-Gel Technologies Ltd. -28.96 Million USD 77.703%
Rhythm Pharmaceuticals, Inc. -168.46 Million USD 96.167%
United Therapeutics Corporation 1.38 Billion USD 100.466%
Creative Medical Technology Holdings, Inc. -5.52 Million USD -16.875%
BriaCell Therapeutics Corp. -4.77 Million USD -35.339%
Lixte Biotechnology Holdings, Inc. 3207.00 USD 201471.999%
Silo Pharma, Inc. -3.62 Million USD -78.092%
Telomir Pharmaceuticals, Inc. Common Stock -6.11 Million USD -5.582%
Pharming Group N.V. 9.87 Million USD 165.384%
XOMA Corporation -39.36 Million USD 83.593%
Reviva Pharmaceuticals Holdings, Inc. -24.11 Million USD 73.217%
Bionomics Limited -9.83 Million USD 34.35%
Alpha Tau Medical Ltd. -34.6 Million USD 81.338%
Pyxis Oncology, Inc. -78.49 Million USD 91.773%
uniQure N.V. -253.1 Million USD 97.448%
Xilio Therapeutics, Inc. -73.8 Million USD 91.25%
Cassava Sciences, Inc. -95.68 Million USD 93.251%
60 Degrees Pharmaceuticals, Inc. -1.42 Million USD -352.702%
Windtree Therapeutics, Inc. -20.15 Million USD 67.965%
Poseida Therapeutics, Inc. -129.5 Million USD 95.013%
Pluri Inc. -20.22 Million USD 68.069%
Anebulo Pharmaceuticals, Inc. -8.05 Million USD 19.781%
MeiraGTx Holdings plc -57.05 Million USD 88.681%
Cidara Therapeutics, Inc. -24.36 Million USD 73.495%
ProMIS Neurosciences, Inc. -17.8 Million USD 63.739%
CalciMedica, Inc. -34.18 Million USD 81.111%
Sana Biotechnology, Inc. -252.39 Million USD 97.441%
Amicus Therapeutics, Inc. -92.07 Million USD 92.986%
Salarius Pharmaceuticals, Inc. -12.88 Thousand USD -50020.723%
Alpha Tau Medical Ltd. -34.6 Million USD 81.338%
Adlai Nortye Ltd. American Depositary Shares -101.21 Million USD 93.62%
Nutriband Inc. -5.12 Million USD -26.089%
Protara Therapeutics, Inc. -43.27 Million USD 85.076%
Compugen Ltd. -12.51 Million USD 48.402%
Roivant Sciences Ltd. -996.51 Million USD 99.352%
ProKidney Corp. -147.66 Million USD 95.627%
Protagenic Therapeutics, Inc. -4.49 Million USD -43.551%
Elevai Labs, Inc. Common Stock -4.27 Million USD -51.229%
Tango Therapeutics, Inc. -111.75 Million USD 94.221%
Renovaro Biosciences Inc. -79.51 Million USD 91.878%
Zevra Therapeutics, Inc. -48.59 Million USD 86.711%
Benitec Biopharma Inc. -22.49 Million USD 71.285%
GeoVax Labs, Inc. -26.66 Million USD 75.784%
Biomea Fusion, Inc. -124.62 Million USD 94.818%
Cullinan Oncology, Inc. -190.33 Million USD 96.607%
4D Molecular Therapeutics, Inc. -107.11 Million USD 93.971%
Kiniksa Pharmaceuticals, Ltd. -22.85 Million USD 71.744%
Nuvectis Pharma, Inc. -22.89 Million USD 71.795%
Spyre Therapeutics, Inc. -242.3 Million USD 97.335%
Ventyx Biosciences, Inc. -207.83 Million USD 96.893%
Imunon, Inc. -19.87 Million USD 67.512%
BioAtla, Inc. -122.24 Million USD 94.717%
Allogene Therapeutics, Inc. -300.29 Million USD 97.849%
Larimar Therapeutics, Inc. -41.44 Million USD 84.419%
Zura Bio Limited -60.56 Million USD 89.337%
aTyr Pharma, Inc. -52.17 Million USD 87.623%
Madrigal Pharmaceuticals, Inc. -379.96 Million USD 98.3%
Viridian Therapeutics, Inc. -234.56 Million USD 97.247%
Galecto, Inc. -37.51 Million USD 82.787%
Tevogen Bio Holdings Inc. 188.7 Thousand USD 3522.255%
Halozyme Therapeutics, Inc. 451.94 Million USD 101.429%
Lexicon Pharmaceuticals, Inc. -163.46 Million USD 96.049%
PolyPid Ltd. -20.26 Million USD 68.129%
Aileron Therapeutics, Inc. -15.61 Million USD 58.637%
Forte Biosciences, Inc. -32.47 Million USD 80.115%
Xencor, Inc. -125.87 Million USD 94.869%
Coeptis Therapeutics Holdings, Inc. -20.15 Million USD 67.962%
Lexaria Bioscience Corp. -6.38 Million USD -1.086%
Instil Bio, Inc. -146.12 Million USD 95.58%
Cardio Diagnostics Holdings, Inc. -1.53 Million USD -322.036%
OncoCyte Corporation -23.12 Million USD 72.071%
Elevation Oncology, Inc. -41.46 Million USD 84.426%
Purple Biotech Ltd. -22.22 Million USD 70.943%
CollPlant Biotechnologies Ltd. -6.41 Million USD -0.749%
MacroGenics, Inc. 2.01 Million USD 420.178%
Verona Pharma plc -52.46 Million USD 87.691%
Tharimmune, Inc. -9.3 Million USD 30.578%
Apogee Therapeutics, Inc. -83.98 Million USD 92.311%
enGene Holdings Inc. Warrants -94.77 Million USD 93.186%
Aditxt, Inc. -25.45 Million USD 74.633%
XTL Biopharmaceuticals Ltd. -764 Thousand USD -745.288%
Savara Inc. -59.13 Million USD 89.079%
Curis, Inc. -45.13 Million USD 85.693%
Carmell Therapeutics Corporation -15.19 Million USD 57.488%
Achieve Life Sciences, Inc. -26.73 Million USD 75.843%
BeiGene, Ltd. -1.12 Billion USD 99.426%
Protagenic Therapeutics, Inc. -4.49 Million USD -43.551%
Vincerx Pharma, Inc. -42.6 Million USD 84.844%
Plus Therapeutics, Inc. -12.69 Million USD 49.122%
Acrivon Therapeutics, Inc. Common Stock -59.85 Million USD 89.21%
Rigel Pharmaceuticals, Inc. -16.98 Million USD 61.969%
Adicet Bio, Inc. -136.53 Million USD 95.27%
Estrella Immunopharma, Inc. -7.31 Million USD 11.656%
Quantum-Si incorporated -91.8 Million USD 92.965%
Acurx Pharmaceuticals, Inc. - USD Infinity%
Generation Bio Co. -133.3 Million USD 95.155%
Black Diamond Therapeutics, Inc. -86.02 Million USD 92.493%
Invivyd, Inc. -196.61 Million USD 96.715%
Relay Therapeutics, Inc. -374.15 Million USD 98.274%
Quoin Pharmaceuticals, Ltd. -9.27 Million USD 30.37%
Moolec Science SA -52.07 Million USD 87.599%
Clearside Biomedical, Inc. -23.05 Million USD 71.992%
Longboard Pharmaceuticals, Inc. -56.75 Million USD 88.621%
Relmada Therapeutics, Inc. 4.91 Million USD 231.521%
ALX Oncology Holdings Inc. -158.4 Million USD 95.923%
Vir Biotechnology, Inc. -684.3 Million USD 99.056%
Evaxion Biotech A/S -21.4 Million USD 69.827%
Ocular Therapeutix, Inc. -66.41 Million USD 90.276%
Tyra Biosciences, Inc. -79.59 Million USD 91.886%
Unity Biotechnology, Inc. -37.28 Million USD 82.678%
Connect Biopharma Holdings Limited -58.37 Million USD 88.936%
Clearmind Medicine Inc. -8.71 Million USD 25.861%
Aadi Bioscience, Inc. -65.36 Million USD 90.12%
Catalyst Pharmaceuticals, Inc. 86.81 Million USD 107.439%
CERo Therapeutics Holdings, Inc. -2.44 Million USD -164.519%
Viking Therapeutics, Inc. -100.82 Million USD 93.595%
Keros Therapeutics, Inc. -152.17 Million USD 95.756%
Crinetics Pharmaceuticals, Inc. -221.51 Million USD 97.085%
ImmunityBio, Inc. -436.18 Million USD 98.519%
Korro Bio, Inc. -80.9 Million USD 92.018%
Kineta, Inc. -15.71 Million USD 58.903%
BioVie Inc. -31.95 Million USD 79.787%
Codexis, Inc. -49.28 Million USD 86.896%
Celularity Inc. -183.94 Million USD 96.489%
Virax Biolabs Group Limited -6.6 Million USD 2.287%
Cibus, Inc. -314.58 Million USD 97.947%
Annexon, Inc. -141.57 Million USD 95.438%
Assembly Biosciences, Inc. -64.19 Million USD 89.94%
Eyenovia, Inc. -24.1 Million USD 73.21%
Puma Biotechnology, Inc. 44.78 Million USD 114.42%
NeurAxis, Inc. -6.66 Million USD 3.098%
Regulus Therapeutics Inc. -30.88 Million USD 79.088%
Compass Therapeutics, Inc. -48.47 Million USD 86.677%
TFF Pharmaceuticals, Inc. -20.74 Million USD 68.863%
Notable Labs, Ltd. -14.4 Million USD 55.153%
IN8bio, Inc. -28.5 Million USD 77.344%
DiaMedica Therapeutics Inc. -19.3 Million USD 66.553%
Vera Therapeutics, Inc. -102.01 Million USD 93.669%
Lumos Pharma, Inc. -36.57 Million USD 82.341%
Liquidia Corporation -70.05 Million USD 90.781%
Mustang Bio, Inc. -48.06 Million USD 86.563%
Quantum-Si incorporated -91.8 Million USD 92.965%
Arbutus Biopharma Corporation -70.98 Million USD 90.902%
enGene Holdings Inc. Common Stock -94.77 Million USD 93.186%
ARS Pharmaceuticals, Inc. -67.44 Million USD 90.425%
180 Life Sciences Corp. -22.13 Million USD 70.823%
Vaxcyte, Inc. -464.88 Million USD 98.611%
Xenon Pharmaceuticals Inc. -210.51 Million USD 96.932%
Estrella Immunopharma, Inc. -7.31 Million USD 11.656%
NKGen Biotech, Inc. Warrants -28.54 Million USD 77.374%
Opiant Pharmaceuticals, Inc. 5.82 Million USD 210.786%
CERo Therapeutics Holdings, Inc. -2.44 Million USD -164.519%
Soleno Therapeutics, Inc. -37.03 Million USD 82.56%
PepGen Inc. -83.58 Million USD 92.273%
Moleculin Biotech, Inc. -29.5 Million USD 78.111%
Solid Biosciences Inc. -93.43 Million USD 93.088%
Palisade Bio, Inc. -12.28 Million USD 47.415%
Nutriband Inc. -5.12 Million USD -26.089%
Conduit Pharmaceuticals Inc. -324 Thousand USD -1893.21%
Immuneering Corporation -58.06 Million USD 88.877%
Belite Bio, Inc -31.52 Million USD 79.517%
CG Oncology, Inc. Common stock -55.43 Million USD 88.35%
GeoVax Labs, Inc. -26.66 Million USD 75.784%
Tourmaline Bio, Inc. -45.37 Million USD 85.768%
Altimmune, Inc. -87.93 Million USD 92.656%
Peak Bio, Inc. -1356.23 USD -476072.921%
SeaStar Medical Holding Corporation -11.14 Million USD 42.034%
FibroBiologics, Inc. Common Stock -15.9 Million USD 59.386%
Neurogene Inc. -52.28 Million USD 87.649%
Mirum Pharmaceuticals, Inc. -136.49 Million USD 95.269%
Kintara Therapeutics, Inc. -8.39 Million USD 23.082%
CARGO Therapeutics, Inc. Common Stock -93.01 Million USD 93.057%
Sesen Bio, Inc. -50.84 Million USD 87.297%
argenx SE -216.02 Million USD 97.011%
NKGen Biotech, Inc. Common Stock -28.54 Million USD 77.374%
Dianthus Therapeutics, Inc. -48.17 Million USD 86.594%
Immunome, Inc. -28.27 Million USD 77.157%
Enveric Biosciences, Inc. -17.13 Million USD 62.322%
Design Therapeutics, Inc. -66.32 Million USD 90.263%
Seelos Therapeutics, Inc. -37.75 Million USD 82.893%
Enliven Therapeutics, Inc. -81.93 Million USD 92.118%
Iovance Biotherapeutics, Inc. -427.43 Million USD 98.489%
Taysha Gene Therapies, Inc. -105.19 Million USD 93.861%
Inovio Pharmaceuticals, Inc. -130.39 Million USD 95.047%
Athira Pharma, Inc. -116.7 Million USD 94.466%
XOMA Corporation -39.36 Million USD 83.593%
Merus N.V. -149.2 Million USD 95.672%
Quince Therapeutics, Inc. -31.26 Million USD 79.341%
Rezolute, Inc. -68.42 Million USD 90.562%
Clene Inc. -43.24 Million USD 85.065%
Indaptus Therapeutics, Inc. -15.42 Million USD 58.125%
BeyondSpring Inc. -21.54 Million USD 70.019%
Synlogic, Inc. -55.16 Million USD 88.292%
Allarity Therapeutics, Inc. -12.08 Million USD 46.553%
Phio Pharmaceuticals Corp. -10.64 Million USD 39.316%
Peak Bio, Inc. -1356.23 USD -476072.921%
Werewolf Therapeutics, Inc. -32.46 Million USD 80.108%
Krystal Biotech, Inc. 17.9 Million USD 136.07%
Karyopharm Therapeutics Inc. -118.42 Million USD 94.547%
SpringWorks Therapeutics, Inc. -341.34 Million USD 98.108%
Lipella Pharmaceuticals Inc. -4.6 Million USD -40.195%
MannKind Corporation 15.12 Million USD 142.686%
Ikena Oncology, Inc. -74.39 Million USD 91.32%
Cyclerion Therapeutics, Inc. -12.59 Million USD 48.718%
Gyre Therapeutics, Inc. 20.32 Million USD 131.771%
Gossamer Bio, Inc. -172.15 Million USD 96.249%
CohBar, Inc. -12.06 Million USD 46.477%
Cognition Therapeutics, Inc. -25.5 Million USD 74.683%
NRx Pharmaceuticals, Inc. -30.02 Million USD 78.491%
Legend Biotech Corporation -477.87 Million USD 98.649%
Mural Oncology plc -192.72 Million USD 96.649%
Disc Medicine, Inc. -91.02 Million USD 92.905%
Champions Oncology, Inc. -5.05 Million USD -27.78%
REGENXBIO Inc. -239.46 Million USD 97.303%
Ensysce Biosciences, Inc. -10.71 Million USD 39.747%
Anavex Life Sciences Corp. -55.75 Million USD 88.417%
Cellectar Biosciences, Inc. -38.76 Million USD 83.342%
Edgewise Therapeutics, Inc. -112.8 Million USD 94.275%
Vaxart, Inc. -74.72 Million USD 91.357%
PharmaCyte Biotech, Inc. - USD Infinity%
Aldeyra Therapeutics, Inc. -35.2 Million USD 81.658%
Cellectis S.A. -98.09 Million USD 93.417%
Longeveron Inc. -20.06 Million USD 67.807%
Repare Therapeutics Inc. -114.27 Million USD 94.349%
Sarepta Therapeutics, Inc. -439.19 Million USD 98.53%
Inozyme Pharma, Inc. -74.81 Million USD 91.368%
Revolution Medicines, Inc. -430.58 Million USD 98.5%
Nymox Pharmaceutical Corporation -6.28 Million USD -2.687%
Third Harmonic Bio, Inc. -30.78 Million USD 79.025%
ArriVent BioPharma, Inc. Common Stock -74.59 Million USD 91.342%
AN2 Therapeutics, Inc. 4.9 Million USD 231.715%
Anixa Biosciences, Inc. -10.96 Million USD 41.104%
Vertex Pharmaceuticals Incorporated 4.6 Billion USD 100.14%
Denali Therapeutics Inc. -179.97 Million USD 96.412%
Revelation Biosciences, Inc. -95.2 Thousand USD -6683.043%
Veru Inc. -89.97 Million USD 92.822%
Corvus Pharmaceuticals, Inc. -26.87 Million USD 75.973%
Cingulate Inc. -22.95 Million USD 71.863%
Passage Bio, Inc. -98.34 Million USD 93.433%
Context Therapeutics Inc. -25.06 Million USD 74.23%
Exicure, Inc. -15.53 Million USD 58.44%
Day One Biopharmaceuticals, Inc. -206.06 Million USD 96.866%
Oramed Pharmaceuticals Inc. -36.97 Million USD 82.535%
Scinai Immunotherapeutics Ltd. -5.96 Million USD -8.309%
Nuvalent, Inc. -149.49 Million USD 95.68%
ABVC BioPharma, Inc. -8.13 Million USD 20.589%
Carisma Therapeutics, Inc. -85.89 Million USD 92.481%
Unicycive Therapeutics, Inc. -30.17 Million USD 78.6%
OmniAb, Inc. -49.73 Million USD 87.014%
Anew Medical, Inc. -1.3 Million USD -396.448%
Fennec Pharmaceuticals Inc. -12.36 Million USD 47.768%
Lipocine Inc. -16.32 Million USD 60.435%
Lexeo Therapeutics, Inc. Common Stock -66.67 Million USD 90.313%
Nautilus Biotechnology, Inc. -74.3 Million USD 91.309%
SAB Biotherapeutics, Inc. -38.13 Million USD 83.065%
G1 Therapeutics, Inc. -39.01 Million USD 83.447%
Bellerophon Therapeutics, Inc. -22.18 Million USD 70.888%
Sage Therapeutics, Inc. -545.07 Million USD 98.815%
Ocugen, Inc. -64.82 Million USD 90.038%
Mind Medicine (MindMed) Inc. -92.57 Million USD 93.024%
Q32 Bio Inc. -86.5 Million USD 92.534%
Brainstorm Cell Therapeutics Inc. -16.92 Million USD 61.848%
Alumis Inc. Common Stock -156.89 Million USD 95.884%
Equillium, Inc. -12.13 Million USD 46.795%
Kyverna Therapeutics, Inc. -58.47 Million USD 88.955%
Coya Therapeutics, Inc. -7.9 Million USD 18.288%
CNS Pharmaceuticals, Inc. -18.86 Million USD 65.76%
Dominari Holdings Inc. -22.44 Million USD 71.221%
Edesa Biotech, Inc. -8.19 Million USD 21.149%
vTv Therapeutics Inc. -25.41 Million USD 74.587%
Bio-Techne Corporation 326.66 Million USD 101.977%
Agios Pharmaceuticals, Inc. -384.86 Million USD 98.322%
Harmony Biosciences Holdings, Inc. 216.38 Million USD 102.984%
Prelude Therapeutics Incorporated -131.1 Million USD 95.074%
Candel Therapeutics, Inc. -37.43 Million USD 82.747%
iTeos Therapeutics, Inc. -151.1 Million USD 95.726%
Nkarta, Inc. -120.48 Million USD 94.64%
BioCardia, Inc. -11.56 Million USD 44.135%
Iterum Therapeutics plc -34.58 Million USD 81.324%